WallStSmart
OSCR

Oscar Health Inc

NYSE: OSCR · HEALTHCARE · HEALTHCARE PLANS

$17.93
-0.61% today

Updated 2026-04-29

Market cap
$5.40B
P/E ratio
P/S ratio
0.46x
EPS (TTM)
$-1.69
Dividend yield
52W range
$11 – $24
Volume
6.5M

Oscar Health Inc (OSCR) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-6.8%
Last 4 quarters
Revenue YoY growth
+17.3%
Most recent quarter
EPS YoY growth
-100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+7.1%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+9.7%
2025-08-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-10$-1.24-34.8%$12.66$13.60+7.4%
2025-11-06$-0.53-6.0%$17.03$17.72+4.1%
2025-08-06$-0.89+0.0%$13.82$15.16+9.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.92$-1.24-34.8%$2.81B+17.3%
2025-09-30$-0.50$-0.53-6.0%$2.99B+23.2%
2025-06-30$-0.89$-0.89+0.0%$2.86B+29.0%
2025-03-31$0.81$0.92+13.6%$3.05B+42.2%
2024-12-31$-0.58$-0.62-6.9%$2.39B+67.1%
2024-09-30$-0.18$-0.22-22.2%$2.42B+68.3%
2024-06-30$0.16$0.20+25.0%$2.22B+45.8%
2024-03-31$0.27$0.62+129.6%$2.14B
2023-12-31$-0.70$-0.66+5.7%$1.43B
2023-09-30$-0.47$-0.29+38.3%$1.44B
2023-06-30$-0.16$-0.07+56.3%$1.52B

Frequently asked questions

Has Oscar Health Inc beaten earnings estimates?
Oscar Health Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -6.8% over the last 4 quarters.
How does OSCR stock react to earnings?
OSCR stock has moved an average of +7.1% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Oscar Health Inc's revenue growth rate?
Oscar Health Inc reported year-over-year revenue growth of +17.3% in its most recent quarter, with EPS growing -100.0% year-over-year.